DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Nitz U, Gluz O, Kates RE et al.
Prognostic impact of discordance between different risk assessment tools in early breast cancer (recurrence score, central garde, ki67): early outcome analysis from the prospective phase III WSG-Plan B trial. 2014: P4–11–01.
San Antonio Breast Cancer Symposium 2014;
P4: 11-01
We do not assume any responsibility for the contents of the web pages of other providers.